Recommendations on influenza vaccine for 1982-83
McCarthy, M.A.
Pennsylvania Medicine 85(11): 24
1982
ISSN/ISBN: 0031-4595 PMID: 6891043 Document Number: 183924
Document emailed within 1 workday
Related Documents
2000: Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. Advisory Committee on Immunization Practices Mmwr. Morbidity and Mortality Weekly Report 49(27): 619-622Campos-Outcalt, D. 2004: Influenza vaccine: new recommendations for infants and children aged 6 to 23 months Journal of Family Practice 53(11): 874-877
Fine, M. 2004: The Rhode Island influenza vaccine experience 1995-2003: influenza vaccine price, reimbursement, availability, and Rhode Island's influenza vaccination rate Medicine and Health Rhode Island 87(3): 79-80
Nekliudova, L.I.; Fedorova, I.B.; Orlova, N.G. 1974: Correlation of antineuraminidase antibodies and antihemagglutinins in influenza and following administration of live influenza vaccine Voprosy Virusologii 2: 173-176
1995: CDC releases update on influenza activity and on composition of 1995-96 influenza vaccine American Family Physician 52(1): 298-299
Hahn, H.L.; Mössner, J. 1980: Influenza vaccination of risk patients with trivalent split virus vaccine and subunit vaccine Münchener Medizinische Wochenschrift 122(42): 1477-1480
Hannoun, C. 1973: A new step in influenza vaccination. I. Prospective vaccine against influenza La Nouvelle Presse Medicale 2(18): 1199-1202
Alvarez-Alva, R. 1971: Epidemiologic study on the 1969-1970 influenza outbreak and the antigenic capacity of anti-influenza vaccine. I. Methodology of the epidemiological studies Gaceta Medica de Mexico 101(1): 21-26
Guo, W.; Xu, J.; Wu, J.; Zhao, S.; He, H.; Shi, W.; Yu, D.; Li, J.; Gao, H.; Chen, J. 2014: Safety and immunogenicity of seasonal inactivated influenza vaccine (split virion) and cross-reactive antibody responses to the H7N9 avian influenza virus Zhonghua Liu Xing Bing Xue Za Zhi 35(8): 949-952
LaForce, F.M. 2011: Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: a success story and a window into the future Vaccine 29(Suppl 1): A1
Petrescu, A.; Mihail, A.; Samuel, I.; Teodosiu, O.; Isaia, G.; Ganea, E.; Motaş, C. 1979: Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology Virologie 30(2): 109-115
Cassetti, M.Cristina.; Katz, J.M.; Wood, J. 2006: Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005 Vaccine 24(5): 541-543
2000: From the Centers for Disease Control and Prevention. Update: Influenza activity--United States, and worldwide, 1999-2000 season, and composition of the 2000-2001 influenza vaccine JAMA 283(21): 2781-2783
Füessl, H.S.; Stiefelhagen, P. 2014: STIKO recommendations. Should I vaccinate all patients against influenza MMW Fortschritte der Medizin 156(21-22): 32
Armstrong, C. 2019: Influenza Vaccination: Updated Recommendations from ACIP American Family Physician 100(8): 505-507
Alper, B.S. 2000: Pneumococcal vaccine recommendations American Family Physician 62(12): 2588-2589
Schoub, B.D. 2005: Recommendations pertaining to the use of viral vaccines: influenza, 2005 South African Medical Journal 95(2): 104
Horimoto, T.; Murakami, S.; Kawaoka, Y. 2008: Influenza vaccine Nihon Rinsho. Japanese Journal of Clinical Medicine 66(10): 2013-2018
Palma, A.; Ugazio, A.; Chiamenti, G.; Tozzi, A.; Tucci, P.L.; Zuccotti, G.V.; De Martino, M. 2008: Recommendations of the Italian Pediatricians on anti-Rotavirus vaccine Minerva Pediatrica 60(1): 17
Egorov, P.A.; Pushkarev, M.A.; Vasiaev, A.I.; Ishkil'din, I.B.; Veselov, S.Iu. 1982: Standards of attenuated influenza vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1982(4): 72-74